Pediatrix Medical (MD) Cash from Financing Activities (2009 - 2026)

Pediatrix Medical (MD) has reported Cash from Financing Activities for 18 consecutive years, with -$27.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 357.91% year-over-year to -$27.6 million; the TTM figure through Mar 2026 stood at -$129.1 million (down 33.47% YoY), while the FY2025 annual figure was -$107.5 million, down 642.11% from the prior year.
• Cash from Financing Activities climbed to -$27.6 million in Q1 2026 per MD's latest filing, from -$68.6 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $108.6 million in Q1 2023 and bottomed at -$256.5 million in Q1 2022.
• Historically, Cash from Financing Activities has averaged -$39.0 million across 5 years, with a median of -$28.6 million in 2025.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities tumbled 63000.76% — and 2023, when it soared 142.33%.
• Pediatrix Medical's Cash from Financing Activities stood at -$86.3 million in 2022, then surged by 94.5% to -$4.7 million in 2023, then slipped by 4.55% to -$5.0 million in 2024, then slumped by 1282.99% to -$68.6 million in 2025, then jumped by 59.74% to -$27.6 million in 2026.
• Business Quant data shows MD's Cash from Financing Activities at -$27.6 million in Q1 2026, -$68.6 million in Q4 2025, and -$28.6 million in Q3 2025.